Related Experiment Video
Updated: Jul 8, 2026
07:29
Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Challenging the equipotency calculation for transdermal buprenorphine: four case studies
1Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria. r.likar@aon.at
International Journal of Clinical Practice
|January 5, 2008
Summary
Opioid rotation can be complex. These case studies show transdermal buprenorphine effectively treated pain when other opioids failed, suggesting new conversion ratios may be needed for better pain management.
Area of Science:
- Pain Management
- Pharmacology
- Neurology
Background:
- Opioids are crucial for pain relief, acting through various pain pathways.
- Opioid rotation (switching to a different opioid) is a common strategy when current analgesia is inadequate or side effects occur.
- Accurate conversion ratios between different opioids and routes of administration are essential for safe and effective rotation.
Observation:
- Two cases of neuropathic pain and two cases of nociceptive pain with neuropathic components were studied.
- These patients had previously failed treatment with other opioids.
- Transdermal buprenorphine was administered to these patients.
Findings:
- Transdermal buprenorphine successfully managed pain in all studied cases.
- Effective pain relief was achieved at doses lower than predicted by the standard equipotency ratio (1:75).
- The findings suggest a revised equipotency ratio for transdermal buprenorphine, potentially between 1:110 and 1:115, may be more clinically appropriate.
Implications:
- These findings may necessitate adjustments to current opioid conversion guidelines.
- A more accurate conversion ratio could improve the safety and efficacy of opioid rotation, particularly with transdermal buprenorphine.
- Further research into opioid conversion ratios is warranted to optimize pain management strategies.
Related Concept Videos
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:28IV Infusion to Oral Dosing: Conversion Methods
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:13Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...